153 results
Page 7 of 8
6-K
EX-99.1
sv9 7dwik13xcks7
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.2
5f8y3z9hk43v5d
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
1r9wwyaxx
31 Jul 18
Acasti Pharma Announces Mailing of Management Information Circular and Amendment to Stock Option Plan
5:14pm
6-K
EX-99.1
st6j6
24 Jul 18
Acasti Pharma Awarded Composition-of-Matter Patent by the U.S. Patent and Trademark Office
7:00am
6-K
EX-99.1
7hlsfwcn8nc u4qc0u
2 Jul 18
Current report (foreign)
5:14pm
6-K
EX-99.2
56wbc
27 Jun 18
Current report (foreign)
5:27pm
6-K
EX-99.1
ue7noy1m05arn8d69h
27 Jun 18
Current report (foreign)
5:27pm
6-K
EX-99.1
mk0nbrh
27 Jun 18
Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018
5:01pm
6-K
EX-99.1
sym1va57
6 Jun 18
Acasti Pharma to Present at the XVIII(th) International Symposium on Atherosclerosis
7:00am
6-K
EX-99.1
1n1ke3f
5 Jun 18
Acasti Pharma Appoints Brian Groch as Chief Commercial Officer
12:00am
6-K
EX-99.1
i21stuf4yex
18 May 18
Current report (foreign)
8:44am
6-K
EX-99.1
6v843x7qib5c2dqynhb
14 May 18
Acasti Pharma Announces Full Exercise of Over-Allotment Option
2:32pm
6-K
EX-99.1
4uhw2w6kt gy7jay97
9 May 18
Acasti Pharma Announces Closing of $10 Million Underwritten Offering
5:17pm
6-K
EX-99.1
a20kxh 0l
27 Apr 18
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
8:00am
6-K
EX-99.2
drt9ns1p0 y6wc2v
17 Jul 17
Notice of Annual and Special Meeting of Shareholders
12:00am